CBIO logo

Catalyst Biosciences (CBIO) Cash From Investing

Annual CFI

$55.43 M
+$7.24 M+15.02%

31 December 2022

CBIO Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFI

$0.00
-$4.79 M-100.00%

30 September 2023

CBIO Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFI

$5.26 M
$0.000.00%

30 September 2023

CBIO TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBIO Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+473.6%-100.0%-92.8%
5 y5 years+177.7%-100.0%-83.1%

CBIO Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-100.0%-92.8%

Catalyst Biosciences Cash From Investing History

DateAnnualQuarterlyTTM
Sept 2023
-
$0.00(-100.0%)
$5.26 M(0.0%)
June 2023
-
$4.79 M(+1066.7%)
$5.26 M(-90.1%)
Mar 2023
-
$411.00 K(+705.9%)
$53.33 M(-3.8%)
Dec 2022
$55.43 M(+15.0%)
$51.00 K(>+9900.0%)
$55.43 M(-4.8%)
Sept 2022
-
$0.00(-100.0%)
$58.24 M(-10.8%)
June 2022
-
$52.87 M(+2011.5%)
$65.28 M(+182.4%)
Mar 2022
-
$2.50 M(-12.6%)
$23.11 M(-52.0%)
Dec 2021
$48.19 M(+398.7%)
$2.87 M(-59.3%)
$48.19 M(-33.9%)
Sept 2021
-
$7.04 M(-34.2%)
$72.87 M(+63.5%)
June 2021
-
$10.70 M(-61.2%)
$44.57 M(+353.7%)
Mar 2021
-
$27.58 M(+0.1%)
$9.82 M(+1.7%)
Dec 2020
$9.66 M(-64.7%)
$27.55 M(-229.5%)
$9.66 M(-155.4%)
Sept 2020
-
-$21.27 M(-11.5%)
-$17.45 M(-194.6%)
June 2020
-
-$24.04 M(-187.7%)
$18.45 M(-60.0%)
Mar 2020
-
$27.42 M(+6132.0%)
$46.15 M(+68.5%)
Dec 2019
$27.39 M(-138.4%)
$440.00 K(-97.0%)
$27.39 M(-11.9%)
Sept 2019
-
$14.63 M(+299.6%)
$31.11 M(+142.2%)
June 2019
-
$3.66 M(-57.7%)
$12.84 M(-120.2%)
Mar 2019
-
$8.66 M(+108.5%)
-$63.46 M(-11.0%)
Dec 2018
-$71.32 M(+537.1%)
$4.16 M(-214.2%)
-$71.32 M(-7.4%)
Sept 2018
-
-$3.64 M(-95.0%)
-$76.99 M(-14.3%)
June 2018
-
-$72.64 M(-9146.2%)
-$89.83 M(+422.6%)
Mar 2018
-
$803.00 K(-152.9%)
-$17.19 M(+53.6%)
Dec 2017
-$11.20 M(+755.9%)
-$1.52 M(-90.8%)
-$11.20 M(+191.8%)
Sept 2017
-
-$16.47 M(>+9900.0%)
-$3.84 M(-125.5%)
June 2017
-
-$1000.00(-100.0%)
$15.02 M(+62.2%)
Mar 2017
-
$6.80 M(+16.4%)
$9.26 M(-808.1%)
Dec 2016
-$1.31 M(-103.5%)
$5.84 M(+145.1%)
-$1.31 M(-134.2%)
Sept 2016
-
$2.38 M(-141.4%)
$3.83 M(-200.0%)
June 2016
-
-$5.76 M(+52.7%)
-$3.83 M(-130.5%)
Mar 2016
-
-$3.77 M(-134.4%)
$12.55 M(-66.4%)
Dec 2015
$37.36 M(+10.3%)
$10.97 M(-308.3%)
$37.36 M(-8.1%)
Sept 2015
-
-$5.27 M(-149.6%)
$40.63 M(-27.6%)
June 2015
-
$10.61 M(-49.5%)
$56.09 M(+5.9%)
Mar 2015
-
$21.04 M(+47.6%)
$52.96 M(+56.4%)
Dec 2014
$33.86 M
$14.25 M(+40.0%)
$33.86 M(+43.8%)
Sept 2014
-
$10.18 M(+36.1%)
$23.54 M(+7.5%)
June 2014
-
$7.48 M(+286.8%)
$21.90 M(+20.4%)
DateAnnualQuarterlyTTM
Mar 2014
-
$1.94 M(-50.8%)
$18.20 M(+35.7%)
Dec 2013
$13.41 M(-66.3%)
$3.94 M(-54.0%)
$13.41 M(-47.0%)
Sept 2013
-
$8.55 M(+126.3%)
$25.31 M(-24.4%)
June 2013
-
$3.78 M(-232.4%)
$33.49 M(+11.0%)
Mar 2013
-
-$2.85 M(-118.0%)
$30.18 M(-24.2%)
Dec 2012
$39.82 M(-169.1%)
$15.83 M(-5.4%)
$39.82 M(+82.7%)
Sept 2012
-
$16.74 M(+3538.3%)
$21.80 M(-256.4%)
June 2012
-
$460.00 K(-93.2%)
-$13.94 M(-69.3%)
Mar 2012
-
$6.79 M(-410.0%)
-$45.34 M(-21.4%)
Dec 2011
-$57.67 M(-8.2%)
-$2.19 M(-88.5%)
-$57.67 M(-6.6%)
Sept 2011
-
-$19.00 M(-38.6%)
-$61.71 M(-1.7%)
June 2011
-
-$30.94 M(+458.5%)
-$62.75 M(+22.6%)
Mar 2011
-
-$5.54 M(-11.2%)
-$51.17 M(-18.5%)
Dec 2010
-$62.80 M(-740.8%)
-$6.24 M(-68.9%)
-$62.80 M(+10.9%)
Sept 2010
-
-$20.04 M(+3.6%)
-$56.61 M(+54.7%)
June 2010
-
-$19.35 M(+12.7%)
-$36.60 M(+403.0%)
Mar 2010
-
-$17.17 M(>+9900.0%)
-$7.28 M(-174.2%)
Dec 2009
$9.80 M(-277.6%)
-$48.00 K(+60.0%)
$9.80 M(+105.2%)
Sept 2009
-
-$30.00 K(-100.3%)
$4.78 M(-52.2%)
June 2009
-
$9.97 M(<-9900.0%)
$9.98 M(+30.0%)
Mar 2009
-
-$93.00 K(-98.2%)
$7.68 M(-239.2%)
Dec 2008
-$5.52 M(-79.0%)
-$5.07 M(-198.0%)
-$5.52 M(-592.3%)
Sept 2008
-
$5.18 M(-32.5%)
$1.12 M(-104.9%)
June 2008
-
$7.67 M(-157.7%)
-$22.88 M(-41.3%)
Mar 2008
-
-$13.29 M(-947.4%)
-$38.97 M(+48.3%)
Dec 2007
-$26.29 M(+98.1%)
$1.57 M(-108.3%)
-$26.29 M(-6.7%)
Sept 2007
-
-$18.82 M(+123.5%)
-$28.18 M(+196.7%)
June 2007
-
-$8.42 M(+1281.9%)
-$9.50 M(-30.6%)
Mar 2007
-
-$609.40 K(+89.0%)
-$13.69 M(+3.2%)
Dec 2006
-$13.27 M(+5202.7%)
-$322.40 K(+121.9%)
-$13.27 M(+2.4%)
Sept 2006
-
-$145.30 K(-98.8%)
-$12.96 M(+1.1%)
June 2006
-
-$12.61 M(+6490.9%)
-$12.82 M(+3868.1%)
Mar 2006
-
-$191.30 K(+1327.6%)
-$323.00 K(+29.1%)
Dec 2005
-$250.20 K(-100.8%)
-$13.40 K(+235.0%)
-$250.20 K(+5.7%)
Sept 2005
-
-$4000.00(-96.5%)
-$236.80 K(+1.7%)
June 2005
-
-$114.30 K(-3.5%)
-$232.80 K(+96.5%)
Mar 2005
-
-$118.50 K
-$118.50 K
Dec 2004
$30.56 M
-
-

FAQ

  • What is Catalyst Biosciences annual cash flow from investing activities?
  • What is the all time high annual CFI for Catalyst Biosciences?
  • What is Catalyst Biosciences quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Catalyst Biosciences?
  • What is Catalyst Biosciences TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Catalyst Biosciences?

What is Catalyst Biosciences annual cash flow from investing activities?

The current annual CFI of CBIO is $55.43 M

What is the all time high annual CFI for Catalyst Biosciences?

Catalyst Biosciences all-time high annual cash flow from investing activities is $55.43 M

What is Catalyst Biosciences quarterly cash flow from investing activities?

The current quarterly CFI of CBIO is $0.00

What is the all time high quarterly CFI for Catalyst Biosciences?

Catalyst Biosciences all-time high quarterly cash flow from investing activities is $52.87 M

What is Catalyst Biosciences TTM cash flow from investing activities?

The current TTM CFI of CBIO is $5.26 M

What is the all time high TTM CFI for Catalyst Biosciences?

Catalyst Biosciences all-time high TTM cash flow from investing activities is $72.87 M